Treasury Board of Canada Secretariat
Symbol of the government of Canada

Food and Consumer Safety Action Plan

($ millions)
Federal Partners Federal Partner Program Activity (PA) Names of Programs for Federal Partners Total Allocation (from Start to End Date) Planned Spending for
2009-10
Actual Spending for
2009-10
Expected Results for
2009-10
Results Achieved in
2009-10
Health Canada Health Products Active Prevention 57.6 10.80 10.88 Increased industry awareness and knowledge of regulatory requirements
  • 109 pre-submission meetings for biologics and pharmaceuticals.
  • 59 pre-submission meetings with industry were held for biologics and radiopharmaceuticals.
  • 11 oncology pre-submission meetings were held.
  • 5 oncology submissions that had a pre-submission meeting have been received. 2 are in screening and 3 have been accepted for review.
  • Survey not yet planned for - too early to report on this indicator.
  • Post Market Reporting Compliance = 100% of establishments inspected were found to be at an acceptable level of compliance to the Food and Drugs Act (FDA).
  • Human = 96.3% of clinical trials inspected were found to be at an acceptable level of compliance to the FDA.
  • Good Clinical Practice = 90% of clinical trials inspected were found to be at an acceptable level of compliance to the FDA.
Enhanced knowledge of post-market health product safety risks to inform decisions
  • Pharmacovigilance Plans (PvP) received and reviewed for 2009-10
    • Received: 30
    • Reviewed: 25
  • Service Standards for PvP are being developed and being piloted.
  • No PvP were rejected, although deficiencies (if present) were noted and passed on to the Market Authorization Holders (MAH).
Increased oversight of the risk management and risk mitigation strategies for health products
  • Guidance Documents specifically on Risk Management Plans - 4:
    • Questions and Answers regarding the Implementation of Risk Management
    • Planning Notice Regarding Implementation of Risk Management Planning including the adoption of International Conference on Harmonisation (ICH) Guidance Pharmacovigilance Planning - ICH Topic E2E
    • Description of Current Risk Communication Documents for Marketed Health Products for Human Use Standard Operating Procedure (SOP) - Issuance of Health Professional Communications
    • Public Communications by Sponsors
  • Risk Management Mitigation Plan (RMMP) Received: 30
  • Risk Management Program (RMP) Reviewed: 25
  • 100% of RMMP received were considered satisfactory, after clarification received from Market Authorization Holders (MAH)
Increased safety of Active Pharmaceutical Ingredients (API) through industry compliance with the FDA and its regulations
  • Consultation with industry and other government departments completed on proposed regulatory framework.
  • API inspections on hold pending regulatory amendment
  • Stakeholder consultations on the proposed framework on Schedule - Consultation with industry and other government departments completed.
Improved timeliness of pre-market reviews
  • Human Drugs - New Drug Submissions (NDS), Supplemental New Drug Submissions (SNDS), Abbreviated New Drug Submissions (ANDS), and Supplemental Abbreviated New Drug Submissions (SANDS) combined - 63% of decisions made met 90% performance target.
  • Alternatively, when reported as new drugs vs. generics, performance was much better for new drugs with 80% meeting target (NDS (72%), SNDS (83%)). For generic drugs, 44% met target (ANDS (36%) and SANDS (71%)). The Pharmaceutical Human Drugs program continues to focus its efforts on increasing the timeliness of its pre-market decisions while targeting reduction of backlogs in both Clinical and Generic Reviews.
  • This fiscal year, efforts were made to find efficiencies in-house, and by applying strategic use of external scientific contracting.
  • Note: *No new hires. Funding is for review staff hired under Therapeutic Access Strategy (TAS). In addition, TAS funding was lower in FY 2009-10.
  • BGTD maintained its target of 90% of decisions issued within target for all submission types except NDS.
Type # reviewed % within target
ANDS 1 100%
NDS 18 66.7%
SNDS 76 89.5%
CTA 245 99.2%
CTA-A 471 99.8%
NC 433 93.8%
DIN B 37 91.9%
Increased awareness and understanding of the safe use of health products by consumers and health care professionals
  • A total of 52 stakeholders met with the ADM in a series of six bilateral and multilateral meetings held under the ADM Stakeholder Meeting Program. Evaluation performed and follow-up action tracked.
  • Performance evaluation of paediatric cough and cold outreach campaign completed and shared with stakeholders.
  • Research, internal and external consultations and needs analysis completed towards the development of a proposal to create a patient and consumer pool from which the Branch can draw engaged and informed stakeholders to participate in decision-making.
  • E-learning module for patient and consumer stakeholders drafted.
  • Establishing baseline data and developing tracking tools to determine number of consumers aware of risks associated with health products imported for personal use.
1. General Documents Posted by MHPD on HC Website in
  1. 3 - Risk Management & Intervention
  2. 2 - Info Gathering, Monitoring & Processing
  3. 2 - Other
2. Risk Communication Advisories/Warnings posted to HC Website (MedEffect Canada):
  1. HC issued: 108
  2. MAH issued: 60
  • TPD notes that no new hires due to budgetary constraints.
  • Creation of a Health Products Web content safety map identifying all health product Web information in preparation for adding new and revised content to the Consumer Safety Portal.
  • An analysis of all Public Opinion Research related to consumer, food and health product safety completed.
  • Development of a consumer-friendly advisory template and a department-wide standard operating procedure for the production of risk communications; improved use of social media (particularly Twitter) for the dissemination of advisories, warnings and recalls.
Health Canada Health Products Targeted Oversight 34.6 3.90 2.07 Enhanced capacity of HC and industry to identify and respond to risk issues
  • Periodic Safety Update Reporting (PSUR) received/reviewed 2009-2010
  • Marketed Health Products Directorate (MHPD) Level I (Screening) - 104/68 + 71/71 = 175/139
  • MHPD Level II (Full/Targeted) - 37/37 + 56/56 = 93/93
  • TPD (PSUR C) - 20
  • # of new safety signals generated through PSUR reviews:
    • A total of 4 new signals were specifically derived from PSUR review in 2008-09.
    • More complete statistics will be available for 2010-11, as until recently the process has been to review PSURs for which we already suspect some potential issues and that review takes the format of an "improved" Level II review.
  • For the purpose of setting up a tracking system for PSUR, funding from HPFB- MHPD was transferred to HPFB-Therapeutic Products Directorate (TPD).
  • TPD's Submission Processing unit in turn developed a process for putting PSURs into docuBridge® (an electronic based viewing tool) so that these safety reports could be reviewed electronically.
  • The unit also established PSUR tracking capabilities within its Drug Submission Tracking System (DSTS) database.
  • The unit will then provide MHPD with DSTS training and ongoing maintenance/volume reporting as required.
Increased capacity to identify safety issues with health products on the market
  • Relevant legislation regarding Mandatory Reporting (MR) has not yet been passed, therefore, no adverse reactions (AR) have been received under MR.
  • 100% of priority AR reports (outcome of death or life threatening and reports of interest) addressed within established service standard (15 days).
  • Performance standards for all other reports have been implemented for FY 2010-11. Performance standards are being piloted. Results to be analyzed 2010-11 (Note - new legislation is required in order to make reporting mandatory)
  • Some data for Q4 not yet available
  • Pharmaceutical AR Reports received YTD: 11,759
  • Note that a breakdown of completion by product line is not yet available from the Canada Vigilance system
  • Total Domestic AR Reports received (all product lines): 27,139 (increase of 20.7% from previous fiscal year)
  • Domestic AR Reports Completed Workflow: 30,314
  • 100% of AR Reports received are processed, additional reports completed includes reports previously pending workflow completion.
  • Signal Assessment & Review:
    • Signals Prioritized: 29
    • Signals Completed: 54
    • Remaining outstanding: 11
  • Note that a breakdown of Risk Communications by Product Line is not yet available
  • Total Risk Communications Issued:
    • HC Issued: 108 Previous FY: 102
  • Market Authorisation Holders (MAH) Issued: 60 Previous FY: 60
Increased knowledge of post-market drug safety and effectiveness to inform decisions

Increased capacity in Canada to address priority research on post-market drug safety and effectiveness
  • Also see: Canadian Institute for Health Research, Strategic Priority Research, Targeted Oversight
  • DSEN partners have engaged international partners implementing related initiatives (e.g. EnCepp in EU; Sentinel in U.S) to share best practices and explore opportunities for data sharing.
  • Health Canada (HC) and CIHR collaborated to develop the DSEN Performance Measurement and Evaluation Framework which will be submitted for approval by senior HC and CIHR management in Spring 2010.
  • HC and CIHR collaborated to hold a Best Brains Exchange in March 2010 titled "The Methods Gap: What Can Pharmacoepidemiology Tell Decision Makers About Drug Safety and Effectiveness?" This one day event brought together Canadian and international drug policy decision makers (including senior officials from HPFB) and scientific researchers to discuss and promote international collaboration on actions to improve the availability and quality of information required to make evidence-based decisions. Based on survey, overall participant satisfaction for the event was 84%, with an average score in meeting participants' top two expectations at an average of 76.
  • The Health Canada DSEN Implementation Project Team was established by HPFB. One goal of this Team (composed of representatives from HPFB and FNIHB) is to collate research questions from HC staff for consideration as part of the DSEN's national research agenda. Two calls for HC research questions for the DSEN to undertake were made during this period with questions from the first round submitted to Canadian Institute for Health Research (CIHR) for consideration in the launch of the first DSEN funding opportunity.
Improved ability to monitor and control importation of health products
  • National Customs Refusal Database in final stages of development and planned to be rolled out early FY 10/11. This will permit tracking of shipments refused entry that were referred to Health Canada due to an import alert. Once a database is implemented a target can be established in FY 11/12.
  • All importers of inadmissible health products notified of the violation. Health Canada "Its Your Health" information sheet regarding dangers of buying drugs over the Internet, letter from RCMP regarding counterfeit drugs, copies of Public Warnings/Advisories and/or refusal notices sent to personal use importers as appropriate. Health Canada is looking at other communications pieces to warn Canadians of dangers of counterfeit drugs and medical devices.
Health Canada Health Products Rapid Response Existing Resources 0.00 0.00 Improved ability to respond with better tools when safety incidents occur New tools on hold due to delay in new legislation.
Health Canada Consumer Products Active Prevention 41.0 4.16 2.47 Increased awareness and understanding of product safety obligations by consumer products industry
  • Key to supporting industry awareness of product safety obligations is the development of industry guides for consumer products. In 2009-10 a number of guides were completed (e.g. lighter requirements, children's jewellery, tents, second hand products)
  • Included were updates to the following publications:
    • Guide to Cosmetic Ingredient Labelling
    • Quick Reference Guide to the Hazardous Products Act for Manufacturers, Importers, Distributors and Retailers, 2009.
Increased awareness and understanding of standards by consumer products industry
  • A Memorandum of Agreement with Standards Council of Canada in place to support consumer & small business participation in the National Standards System
  • Implementation and support of ISO product safety standard with Canadian Safety Association
  • Trilateral collaboration between Health Canada, the US Consumer Product Safety Commission (CPSC) and the European Union has begun to identify solutions for addressing corded window covering products.
  • Crib standards and test methods are in the process of being adopted by US CPSC and the American Society for Testing and Materials (ASTM).
  • Machinery Noise Declaration standards have been drafted.
  • Second draft document completed of revisions to the Canadian Mammography Quality Guidelines.
  • Ongoing lead of, and participation in, standards committees, e.g. International Electrotechnical Commission & Organization for International Standardization in areas of acoustics, electromagnetics, X-ray devices & laser and electro optics.
Increased awareness and understanding of consumer product safety issues by consumers
  • Consumer Product Safety publications continue to be popular with stakeholders and the public in general. Is Your Child Safe is the most popular and covers many common subjects relevant to homes with children. Just under 200,000 copies were circulated in both official languages. Second on the list is Safety with Radar - popular for children's events - approximately 50,000 copies were circulated.
  • Launch of the online consumer safety portal with a complete user-friendly section on children's products, social media features, a survey and easy-to-navigate design.
  • Development of a consumer-friendly advisory template and a department-wide standard operating procedure for the production of risk communications; improved use of social media (particularly Twitter) for the dissemination of advisories, warnings and recalls.
  • Promotion of the new consumer product safety online complaint/incident form.
  • Safety Code 6 (2009) associated communications products, such as fact sheets & FAQs have been developed.
  • The following Its Your Health documents were published on the HC Internet: 1) Airport Body Scanners 2) the Safety of Compact Fluorescent Lamps.
  • Drafting of revisions to It's your Health documents 1) Community Noise Annoyance, 2) Aircraft Noise & 3) Personal Stereo Systems Noise (awaiting publication).
  • Updated the HC Internet page on sun safety.
  • Complete analysis of Web sections for Consumer, Food and Health product safety pages (800+ Web pages) was completed
  • New Web page dedicated to showcasing Health Canada's social media
  • Four social bookmarking sites added to the Health Canada site (Digg, Delicious, Facebook and Twitter)
  • New YouTube channel created just for Health Canada and launched December 23, 2009.
  • More than 2,000 followers on Twitter receiving instant updates on consumer recalls, advisories and warnings.
  • Horizontal development of a clear writing guide for the department.
  • Launch of the department's first widget, allowing users to attach a self-updating feed to their own websites for news on Health Canada's advisories, warnings and recalls.
  • The Contact Centre put in place a new software system designed to track and consolidate consumer inquiries (2009 statistics: approximately 22,224 calls and 28,536 emails were handled by the Contact Centre)
Health Canada Consumer Products Targeted Oversight 15.7 2.10 1.15 Improved timeliness and quality of information on consumer product safety
  • In 2009-10 Health Canada, Consumer Product Safety had a total of 7,844 unique subscribers. Consumers are now able to subscribe to product safety information being published (e.g. advisories, warnings and recalls) in both official languages.
  • Product safety complaints/incidents have been steadily increasing over the last four years (2006-07 567 complaints; 2007-08 - 672; 2008-09 - 944; 2009-10 - 1102).
  • Of the 1,102 complaints received in 2009-10, Health Canada met its service targets, responding to 100% of complainants and met its service standard following-up with 100% of companies. Depending on the severity of the incident reported, actions could include product inspection with follow-up and enforcement actions, including recall or public advisory, as appropriate. In addition, follow-up with the companies in question to ensure appropriate actions have been completed.
  • Data suggests the increase in reporting by consumers is linked to the increase in subscriptions to the recall website and is an indicator of increased consumer awareness of risks associated with consumer products.
Improved Cosmetic Regulations under the FDA
  • Amendments to the Cosmetic Regulations under the Food and Drugs Act were drafted, however; amendments were not introduced into the House due to the prorogation of Parliament.
  • Work was initiated on the use of Sunscreen by consumers (for purposes of classification regulation).
  • Through increased capacity and improved efficiency the notification process for cosmetics resulted in the reduction of the backlog to almost zero. Future improvements to IT systems will further improve the processing of notifications.
Increased sharing of information with international regulators
  • Continued implementation of the Memorandum of Understanding with China on the safe manufacturing of consumer products. A number of technical working group meetings were completed.
  • Preliminary discussions have occurred with Vietnam.
  • MOU with EU being addressed under FT negotiations.
  • Ongoing bilateral discussions with the US and Australia.
  • Continued participation as a member of the Scientific Oversight Committee, which oversees the International Electromagnetic Frequency (EMF) Project (World Health Organization). This project gathers information regarding completed, active and proposed research into the effects of electromagnetic radiation on human health.
  • Ongoing lead of, and participation in, standards committees, e.g. International Electrotechnical Commission & Organization for International Standardization in areas of acoustics, electromagnetics, X-ray devices & laser and electro optics.
Health Canada Consumer Products Rapid Response 17.9 3.40 3.95 Improved legislative authority and regulatory tools for consumer products
  • Due to the prorogation of Parliament in 2009-10 the Canada Consumer Product Safety Act (CCPSA) did not receive Royal Assent. The CCPSA (Bill C-36) was re-tabled in the House of Commons on June 9, 2010.
Improved legislative authority and regulatory tools for radiation-emitting devices
  • Completed international environmental scan, and held a consultation workshop with internal Health Canada collaborators.
  • Review and analysis of existing public opinion research and stakeholder concerns listed on the PWGSC web site concerning radiation emitting devices.
  • Developed proposal outlining evidence needed to summarize health and safety risks associated with radiation emitting devices to feed into the Issue Analysis Summary.
  • Legal analysis of REDA authorities is ongoing.
  • Developed work plan for enhanced collaboration with the Medical Devices Bureau and the HPFB Inspectorate.
Improved monitoring of consumer and cosmetic products In 2009-10 compliance and enforcement activities continue as per cyclical enforcement plan:
  • Toys - heavy metals: 2009-2010: 55 samples- 89% compliant (2008-09: 95%)
  • Toys - noise: 2009-2010: 120 samples - 100% compliant (2005-06: 96%)
  • Utility Lighters: 2009-2010: 15 samples- 7% compliant
  • Halloween costumes: 2009-2010: 22 samples- 95% compliant (2008-09: 84.2%)
  • Glazed Ceramics: 2009-2010: 121 samples- 92% compliant (2004-05: 67%)
  • Children's products e.g. furniture, learning products: 2009-2010: 31 samples- 90% compliant (2007-08: 79%)
  • Children's Jewellery: 2009-2010: 107 samples- 60% compliant (2008-09: 74%)
Health Canada Pesticide Regulation Active Prevention 6.9 1.34 1.15 Increased industry (manufacturers and retailers) awareness of risks and related regulatory requirements
  • Completed analysis of information relevant to program design/delivery to be initiated in 2010-11 related to quality assurance for pesticide manufacturing.
  • Contributed to ongoing internal discussions relating to treated articles policy/regulatory approach that included some discussions vis a vis compliance approach.
  • Ongoing work related to vendor knowledge of and related capacity to comply with legislation e.g., only offer for sale registered products.
  • New program methodology for active prevention related to the use of structural pest control products by property managers was developed to provide further insight into causality i.e., why compliance exists/does not exit.
  • Ongoing discussions with FPT on possible consumer product related programs/activities. Some interest related to Active Prevention related to the use of unregistered non conventional products e.g., garlic.
  • Additional work completed aimed at creating further transparency related to compliance work and decisions.
Health Canada Pesticide Regulation Rapid Response 8.0 1.00 0.76 Improved monitoring of pest management products using a risk management approach
  • Targeted inspections were conducted of manufacturers and vendors of consumer products. More than 200 vendors of pet products inspected nationally - with lack of knowledge of regulatory requirements being the key reason for non-compliance.
  • Some work done in relation to border integrity (under HC Improving Together pilot project).
  • Consultations held with US EPA colleagues in relation to common challenges related to imported unregistered products, false and misleading product claims, best practices.
  • In BC, Quebec and Ontario, a number of detected situations of non-compliance resulted in follow up. Many non-compliant consumer products were for use on pets.
Health Canada Food Nutrition Active Prevention 29.6 4.90 4.78 Establishment of the appropriate instrument or mix of instruments, including regulatory and non-regulatory measures (standards, policies, etc.) to address immediate areas of concern HC developed and published several guidance documents that provided Canadians with better information on what they are eating and how to handle food safely, e.g., caffeine, allergens, fresh produce and powdered infant formulas.

As part of its Amendments to the Food Additive Tables, Health Canada published 9 Interim Marketing Authorization notices in Canada Gazette Part I.

Health Canada published in Canada Gazette Part II three regulatory amendments for food additives for a total of 13 submissions. Amendments have been drafted for several other additives and publication is expected in Summer 2010.
Increased understanding of food safety risks by HC, PHAC & CFIA
  • Risk mapping model and tool has been developed and implemented.
  • Risk profiling & prioritization activities underway.
Increased engagement by Canadians in the regulatory system

Increased industry knowledge regarding food labelling
  • Public consultations, including an on-line consultation were completed on the enhancement of the system for precautionary labelling of allergens in food. The purpose of the consultations was to provide stakeholders the opportunity to comment on whether and how precautionary labelling on food should be regulated. As well, HC hosted two technical consultations 1-to permit the use of the enzyme asparigenese -2- Proposed maximum limits for the presence of Mycotoxin Ochratoxin A in foods.
  • Contribution to the Nutrition Facts Education Initiative (NFEI), a collaboration between Health Canada and the food industry's trade association - Food and Consumer Products Canada (FCPC), to help further nutrition labelling education with Canadians.
  • A three-year food safety campaign was launched, starting with relevant Public Opinion Research, development of creative aspects, media planning, printing, and Web development. A radio ad campaign promoting Safe Food Handling for Adults 60+ ran nationally from March 22nd - 31st.
  • More than 90,000 safe food handling HC publications shipped from the distribution centre in 2009-2010.
Increased industry understanding of and engagement in the development and implementation of food safety risk mitigation processes

Improved international collaboration in addressing common import risks
  • The departmententered into a number of formal arrangements (Letters of Understanding, Memoranda of Understanding) with major International regulatory counterparts to enhance collaboration (e.g., European Food safety Authority (EFSA), Australian National Measurements Institute (NMI).) to support rapid information sharing and to facilitate work sharing opportunities.
  • The department formed collaborations with several national and international partners to validate, develop, disseminate and advise on laboratory testing methods related to the four FCSAP priority areas (allergens, natural toxins, emerging foodborne pathogens and bioactives).
  • The Executive Board of the World Health Organization (WHO) adopted the resolution Advancing Food Safety Initiatives. The resolution, led by HC and other Canadian partners, aims to advance global food safety initiatives and augments the recommendations in earlier resolutions.
  • HC has begun to increase its engagement of stakeholders and the public. Most importantly, it has established a Food Regulatory Advisory Committee to provide broad expert advice on matters related to the safety and nutritional quality in food.
Health Canada Food Nutrition Rapid Response 1.3 0.20 0.17 Increased public understanding of food safety risks, alert systems and safety systems
  • A survey was conducted in February 2010 by Ekos for HC, the conclusions of which provided useful information regarding Canadians' knowledge and behaviours related to food safety.
Canadian Food Inspection Agency Food Safety Active Prevention 114.2 20.10 16.40 Increased understanding of food safety risks by HC, PHAC & CFIA
  • Risk mapping model and tool has been developed and implemented.
  • Risk profiling & prioritization activities underway.
Establishment of the appropriate instrument or mix of instruments, including regulatory and non-regulatory measures (standards, policies, etc.) to address immediate areas of concern
  • Development of proposed regulatory regime for the imported food sector.
Increased industry understanding of and engagement in the development and implementation of food safety risk mitigation processes

Improved international collaboration in addressing common import risks
  • Importer licensing policy approved.
  • Engagement of international partners specifically with through agreements with China, enhancement to Mexico agreement, and with the US.
  • Requirements documentation for identification & verification of IMFS drafted.
  • Internal & government partners consultation complete on Guide to Food Safety.
Increased engagement by Canadians in the regulatory system

Increased industry knowledge regarding food labelling
  • Consultations planned for the purposes of regulatory amendments.
  • CFIA conducted consultations with stakeholders on Guide to Food Safety.
Canadian Food Inspection Agency Food Safety Targeted Oversight 77.0 13.20 8.30 Increased verification of industry food safety measures
  • 9 new inspector training courses are in various stages of development to support enhanced inspection.
Improved ability to monitor and control importation of food
  • Preliminary Project Approval (PPA) for the IM/IT Enabled Business Projects granted by Treasury Board.
  • Implementation of foundational elements under PPA continues.
  • Development of EPA submission for functional enhancements continues.
  • 40 port of entry investigations completed.
  • 107 post-entry verifications conducted.
  • 6 targeted inspections since December 1st (BC West).
Canadian Food Inspection Agency Food Safety Rapid Response 32.2 6.00 8.60 Timely and efficient recall capacity
  • Increased hiring and training of inspection staff.
Increased public understanding of food safety risks, alert systems and safety systems
  • Farm to Fork and Safe Food Handling videos were recorded in February.
  • The public opinion research campaign was launched in February with the goals of identifying the public's confidence in food safety in Canada and other countries, of reporting on awareness of food recalls, and of identifying the resources the public use to gather information on food safety.
  • Brochures for at-risk populations (the elderly, pregnant, and immuno-suppressed) are in progress, and may be released in collaboration with Health Canada, who are working on a similar initiative.
  • The Food Safety Portal has begun to be communicated to establishments such as restaurants and retirement homes, and a social networking strategy is coming into effect.
  • The CFIA is responding to public and industry queries as a result of increased awareness of the FCSAP. A number of stakeholder outreach initiatives, including industry and consumer conferences, information sessions, and workshops.
Public Health Agency of Canada Infectious Disease Prevention and Control Active Prevention 18.3 4.00 3.20 Increased understanding of food safety risks by HC, PHAC, & CFIA
  • Surveillance (C-Enternet) activities were expanded to include sampling/testing to identify high risk imported products to target for prevention.
  • Identification of pathogens; also established MoA and started activity at a second sentinel site in BC.
  • Next-generation laboratory method (MLVA) jointly developed and evaluated for E. coli and Salmonella by PHAC with US CDC.
  • PulseNet Canada is nearing rollout of the E. coli MLVA method to all PulseNet Canada members.
  • New technology platforms have been assessed for future use in increasing capacity for real time surveillance of enteric bacterial disease.
  • Expansion of the capacity of PHAC's web-based outbreak summary reporting system, developed with P/T input, which allows standardized dissemination of the results of disease outbreak investigations. Following the 2008 launch of an Enteric Module of the application in BC, both the Enteric Module and the Respiratory and Vaccine Preventable Disease Module were launched in NS in October 2009. PHAC is working with partners towards the launch of the application in other P/Ts throughout 2010.
  • PHAC - New technology platforms have been assessed for future use in increasing capacity for real time surveillance of enteric bacterial disease.
Public Health Agency of Canada Health Promotion/Chronic Disease Prevention and Control Targeted Oversight 8.0 1.00 0.47 More and better data on accidents, injuries, illnesses and deaths due to consumer products

Engagement of risk assessment stakeholders
  • CCMED database development continued
  • CHIRPP expansion
  • Knowledge translation and dissemination through CHIRPP reports and Injury in Review - focus on Consumer Product Safety
Canadian Institute of Health Research Strategic Priority Research Targeted Oversight 27.1 2.30 1.90 Increased knowledge of post-market drug safety and effectiveness to inform decisions

Increased capacity in Canada to address priority research on post-market drug safety and effectiveness
  • Also see: Health Canada, Health Products, Targeted Oversight
  • The establishment of the DSEN Coordinating Office at CIHR was completed with the appointment of the DSEN Executive Director in January 2010.
  • CIHR opened nominations for membership to the DSEN Steering Committee (DSC) in February 2010. The DSC membership is targeted to be named in Spring 2010. The DSC will advise on the strategic direction and research priorities of the DSEN. Senior management from SPB and HPFB (three members) will represent HC on this committee.
  • CIHR launched the Catalyst Grant: Drug Safety and Effectiveness in Aug 2009 resulting in 14 research projects being funded in March 2010 using the $1 million DSEN grants and an additional $0.33 million funded through partnerships with 5 CIHR Institutes/Initiatives valuing $0.33 million for a total research investment of $1.33 million. The first DSEN research is anticipated to be completed in the spring of 2011, and dissemination of the research evidence and knowledge translation will start after the spring of 2011.
Total 489.4 78.40 66.23    

Comments on Variances:

Health Products In 2009-10 the pre-submission meeting with industry target was not achieved. This was due primarily to backlog and other work load pressures. Additionally, the process has been in place for a number of years, hence there might be an understanding as to when to request a meeting and the type of questions and information that would require a meeting.

The target for mandatory reports processed was not achieved as a result of staff turnover and Branch budget limitations in the Pharmacovigilance unit. Limited staffing now initiated within 2010-11 budget allocations.

With Border Integrity two performance measures listed are not the most representative of the programs success. As the program develops and evolves in 2010/11, the available tools will be reviewed and more representative performance measures will be developed.
Consumer Products Due to the prorogation of Parliament in 2009-10, Royal Assent of the proposed Canada Consumer Product Safety Act did not take place. Several planned activities, including staffing, were deferred which resulted in a variance of ~1M.

The planning schedule for the development of IT systems for Mandatory Reporting of Product Safety Incidents was amended due to delays in the passage of the proposed Canada Consumer Product Safety Act, which includes provisions for mandatory reporting. This resulted in a planned transfer of 1M in O&M funds for system development to be deferred until 2010-11.
Food Safety The second year of the Food and Consumer Safety Action Plan for the CFIA saw a continued effort to provide the necessary training to enhance the capability of for the additional capacity acquired in year one . Additionally, foundational work in a number of areas (e.g. establishment of policies) was completed, which will facilitate achievement of expected outcomes. Funds lapsed are being carried forward.